PF-Atlas › Clinical Trials › NCT03430583

Evaluation of Fontan-associated Hepatic Stiffness and the Efficacy of Udenafil in Reducing Liver Stiffness

Udenafil · Phase 3

Registry ID

NCT03430583

Phase

Phase 3

Status

Completed

Drug / intervention

Udenafil

Sponsor

Mezzion Pharma Co. Ltd

Start

2018-02-20

About this trial

Udenafil is evaluated in NCT03430583, a Phase 3 idiopathic pulmonary fibrosis study sponsored by Mezzion Pharma Co. Ltd. Current status: Completed.

View NCT03430583 on ClinicalTrials.gov →

Explore related

All Udenafil trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT03430583 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.